Lyra Therapeutics, Inc.
Developing localized, long-acting therapies for chronic rhinosinusitis (CRS).
LYRA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 480 ARSENAL WAY, 2472 WATERTOWN
- Website:
- https://lyratherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of innovative therapies for the localized treatment of chronic rhinosinusitis (CRS). The company develops integrated drug and delivery solutions designed to provide long-acting medication directly to sinonasal tissues that are not accessible with conventional therapeutic approaches. Lyra's primary goal is to offer a new, effective, and long-lasting treatment option for the large, underserved population suffering from this debilitating inflammatory disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lyra Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lyra Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lyra Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
